Cigna Q1 Earnings Support A Higher Valuation
Cigna Group (CI) reported strong first-quarter earnings with a 16% increase in adjusted EPS and a 5% rise in revenue, highlighting resilience in its core business. The company raised its 2026 adjusted EPS guidance to at least $30.35, citing margin expansion and ongoing shareholder returns through buybacks and dividends. Despite the positive fundamentals, Cigna trades at a relatively low 9.6x forward P/E ratio, which the analysis suggests supports a higher valuation.
- ▪Cigna reported a 16% year-over-year increase in adjusted earnings per share for the first quarter of 2026.
- ▪Revenue grew 5% during the quarter, driven by performance across its health services and insurance segments.
- ▪The company raised its full-year 2026 adjusted EPS outlook to at least $30.35.
- ▪Cigna maintains a forward P/E ratio of 9.6x, which is considered undervalued relative to its earnings growth and cash flow generation.
- ▪Ongoing share buybacks and dividends reflect disciplined capital deployment and a strong balance sheet.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Earnings Analysis","item":"https://seekingalpha.com/earnings/earnings-analysis"},{"@type":"ListItem","position":3,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4897396-cigna-q1-earnings-support-a-higher-valuation"},"author":{"@type":"Person","name":"Motti…
Excerpt limited to ~120 words for fair-use compliance. The full article is at All Articles on Seeking Alpha.
Discussion
0 commentsMore from All Articles on Seeking Alpha
